Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of zabofloxacin in acute bacterial exacerbation of COPD
KCT0000532Phase 3Completed
- Sponsor
- Dongwha Pharmaceutical Co., Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zabofloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Dongwha Pharmaceutical Co., Ltd.. Started Sep 2012; status: completed.
02
Drugs
zabofloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on KCT0000532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000532.